Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.310
+0.030 (0.70%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $663.48 million as of April 25, 2025. Its market cap has increased by 138.58% in one year.
Market Cap
663.48M
Enterprise Value
863.31M
1-Year Change
138.58%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $663.48M, an increase of 124.32%. That is a compound annual growth rate of 25.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 663.48M | 31.28% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 765.14B |
| UnitedHealth Group | 387.92B |
| Johnson & Johnson | 373.50B |
| AbbVie | 318.15B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |